SCHEMBL937802

SCHEMBL937802

CC1Cc2ncccc2NC1c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.35
GSK3B P49841 1/20 0.35
NLRP3 Q96P20 1/20 0.34
RAB9A P51151 1/20 0.33
HTT P42858 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
P2RX7 Q99572 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
MCL1 Q07820 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28270077 0.76 GAA (0.46) SMN1; SMN2NLRP3P2RX7MEN1MAPT
SCHEMBL28533908 0.76 GAA (0.46) SMN1; SMN2NLRP3P2RX7MEN1MAPT
SCHEMBL13306140 0.76 GAA (0.46) SMN1; SMN2NLRP3P2RX7MEN1MAPT
SCHEMBL25784969 0.75 CREBBP (0.44) GSK3BRAB9AADORA3ADORA2AADORA1
SCHEMBL28531034 0.71 KIF11 (0.39) SMN1; SMN2NLRP3P2RX7MEN1KMT2A
SCHEMBL26620767 0.70 GSK3B (0.37) SMN1; SMN2GSK3BRAB9AKDM4EMEN1
SCHEMBL28371019 0.69 MEN1 (0.41) RAB9AHTTTNKS2KDM4EMEN1
SCHEMBL22570459 0.68 SMN1; SMN2 (0.49) SMN1; SMN2MEN1MAPTKMT2AADORA3
SCHEMBL21121186 0.68 SMN1; SMN2 (0.49) SMN1; SMN2MEN1MAPTKMT2AADORA3
SCHEMBL21121185 0.68 SMN1; SMN2 (0.49) SMN1; SMN2MEN1MAPTKMT2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011009523-A1 EG5 AS BIOMARKER IN RARE THORACIC CANCER MERCK PATENT GMBH (DE) 2011-01-27 WO claimed
EP-1761515-B1 2-(HETERO-)ARYL SUBSTITUTED TETRAHYDROQUINOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2008-11-05 EP claimed
WO-2011009523-A1 EG5 AS BIOMARKER IN RARE THORACIC CANCER MERCK PATENT GMBH (DE) 2011-01-27 WO disclosed
EP-1761515-B1 2-(HETERO-)ARYL SUBSTITUTED TETRAHYDROQUINOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2008-11-05 EP disclosed